Table 1. Clinical Presentation of Four Patients with Mutations in PNLDC1.*.
Variable | Patient 1† | Patient 2 | Patient 3 | Patient 4 |
---|---|---|---|---|
Genetics | ||||
PNLDC1 mutation | Homozygous nonsense | Homozygous missense | Compound heterozygous frameshift and missense | Homozygous splice acceptor variant |
Karyotype | 46,XY | 46,XY | 46,XY | 46,XY |
Y chromosome microdeletions | No | No | No | No |
Patient history | ||||
Age — yr | 32 | 42 | 39 | 36 |
Ethnic origin‡ | Pakistani | Qatari | Unknown | Emirati |
Congenital maldescended testicles | No | No | Unknown | No |
Pubertal development | Normal | Normal | Unknown | Normal |
Psychiatric diagnosis | Schizophrenia | Normal | Unknown | Normal |
Phenotype | ||||
Body-mass index§ | 30 | 26 | Unknown | 20 |
Gynecomastia | No | No | Unknown | No |
Pubic hair growth — Tanner stage¶ | 6 | 6 | Unknown | Unknown |
Hypospadias | No | No | No | No |
Left/right testis position in scrotum | Low/low | Low/low | Low/low | Low/low |
Left/right testis size — ml | 15/12‖ | 10.9/13.0** | Unknown | 10/10‖ |
Epididymis | Bilateral present; not enlarged | Bilateral present; not enlarged | Bilateral present; not enlarged | Bilateral present; not enlarged |
Results of transrectal ultrasonography | Prostate normal; ejaculatory ducts normal | Unknown | Prostate normal; ejaculatory ducts normal | — |
Semen characteristics | ||||
Ejaculation abstinence — days | 3 | 3 | Unknown | 2 |
Semen volume — ml | 1.3–1.5 | 3 | Unknown | 2.3 |
Sperm concentration | Azoospermia | Azoospermia | Azoospermia | Azoospermia |
Spermatozoa in ejaculate pellet | None | None | None | None |
Semen pH | 8.5 | Alkaline | Unknown | 8.0 |
Hormone levels | ||||
Serum total testosterone — nmol/liter | 6–12 | 12 | 16 | 18 |
Serum free testosterone — nmol/liter | 0.14–0.31 | 0.32 | Unknown | Unknown |
Serum SHBG — nmol/liter | 21–23 | 19 | Unknown | Unknown |
Serum FSH — IU/liter | 4.7–4.9 | 4.4 | 7.4 | 4.8 |
Serum LH — IU/liter | 3.4–4.3 | 7.0 | 6.0 | Unknown |
Serum inhibin B — pg/ml | 151–157 | 55 | Unknown | Unknown |
Serum estradiol — pmol/liter | 39–49 | 73 | 115 | Unknown |
Testicular-biopsy sample | ||||
Fixative | Modified Stieve’s fixative | Bouin’s fixative | Unknown | Formalin |
Leydig cell hyperplasia | No | No | Unknown | No |
Spermatogenesis | Bilateral homogenous pattern with spermatogenic arrest at the late pachytene stage | Homogenous pattern with spermatogenic arrest at the late pachytene stage | No biopsy available (only tissue remnants after TESE were available) | Homogenous pattern with spermatogenic arrest at the late pachytene stage |
RNA recovered | Yes | No | Yes, from remnants after TESE | Yes |
Treatments | ||||
TESE or microTESE | Unknown | No sperm identified after extensive TESE | TESE revealed morphologically abnormal spermatozoa | No sperm identified after extensive TESE |
Treatment outcome | Unknown | No pregnancy | No pregnancy after ICSI with abnormal spermatozoa obtained from TESE | No pregnancy |
Patient 1 was from Denmark, Patient 2 from the United States, Patient 3 from Portugal, and Patient 4 from the Netherlands. To convert the values for estradiol to picograms per milliliter, divide by 3.671. To convert the values for testosterone to nanograms per milliliter, divide by 3.467. FSH denotes follicle-stimulating hormone, ICSI intracytoplasmic sperm injection, LH luteinizing hormone, SHBG sex hormone–binding globulin, and TESE testicular sperm extraction.
The reproductive hormones in Patient 1 were measured in several samples, and the range is indicated.
Information on ethnic origin was obtained from the medical records of the patients. The ethnic origin of Patient 3 was unknown, although he had an Arabic name.
The body-mass index is the weight in kilograms divided by the square of the height in meters.
Tanner stages of pubic hair range from 1 to 6, with higher stages indicating more advanced pubertal development.
Testis size was determined by palpation.
Testis size was determined by ultrasonograpy.